Canada to decriminalize several illegal drugs in a three-year trial

0

A Canadian province is set to decriminalize a number of illegal drugs in a three-year trial starting next year.

Starting January 31, 2023, adults in British Columbia will not be arrested if found in possession of up to 2.5g of illegal drugs, including cocaine, methamphetamine and ecstasy. The trial does not cover schools, airports or the military. Cannabis was legalized nationwide in 2018 for adults.

Dr. Theresa Tam, Canada’s chief public health officer, said that the illegality of drugs increases the “risk of harm”.

‘Time bomb’

But researchers and medical professionals have warned that the legalization of cannabis in the United States is increasing psychosis. Currently, cannabis is legal for recreational use in 19 US states and Washington DC.

Dr Beatriz Carlini, of the University of Washington’s Institute of Addiction, Drugs and Alcohol, called the problem a “ticking time bomb”. Although she does not oppose legalization in principle, she is concerned about the increasing potency of the drug with levels of the addictive compound tetrahydrocannabinol (THC) that can reach 90%.

Libby Stuyt, an addiction psychiatrist, said “medical marijuana is a Trojan horse for recreational use” and warned that high-potency cannabis was damaging the mental health of users.

medical marijuana is a Trojan horse for entertainment

Mayor of London

Last month, the mayor of London came under fire for trying to influence the government to decriminalize cannabis.

Sadiq Khan launched the London Drugs Commission to assess Britain’s drug laws, with a focus on whether to decriminalize possession and use of the Class B drug.

Although he is not authorized to enact such changes himself, Khan intends to use the Commission’s report to influence future government policy.

Also see:Cannabis addict talks about the damage of lifelong use

Law student dies after eating cannabis gum

Scottish government scrapped drugs policy as deaths plummeted for first time in 8 years

Share.

About Author

Comments are closed.